23,25,35) that in adult asthmatic patients, atropine-like substances predominantly dilate larger upstream airways and that /3r-symThe bronchodilator~ response of three Pz-agonists (fenoterol, pathomimetics predominantly dilate smaller upstream airways. salbutamol, and terbutaline), administered by a metered aerosol
feature of this fin-mimetic was observed in patients whose lungs These tests fail to detect changes in small airway caliber. Moreover were initially overinflated (functional residual capacity over 120% they are effort and cooperat~on-~epen~ent, ~redicted) but not obstructed before the histamine challenge (P The present study was, therefore, designed to ascertain whether < 0.005). In these subjects C dyn and R1 are normalized after the immediate bronchodilatory response of three Pr-sympathoinhalation of salbutamol. mimetic aerosols (fenoterol, salbutamol, and terbutaline) is similar After fenoterol and terbutaline inhalation, obstruction of the in asthmatic children after histamine respiratory challenge and large airways was not fully alleviated. In addition, these two drugs whether the preferential sites of action of these three drugs can be seemed not to affect the ventilatory asynchronism (C dyn altera-detected within the bronchial tree, tions) in patients whose lungs had been overinflated before drug inhalation (C dyn again around 150% predicted).
PATIENTS AND METHODS

Speculation
Nineteen asthmatic children (10 boys and nine girls, aged On the basis of a distinction between patients with more or less between 5 and 17 yr) were studied after obtaining inf~rmed compliant lungs, as defined by measurements of base line values consent. All patients had a 10% history of moderate or mild of dynamic lung compliance, the search for optimal individual asthma and all had positive skin tests for various pneumoallergens. quantitative and qualitative response to one of the various bronNo upper respiratory tract infection was observed in the 4 wk chodilator drugs seems to be possible and of important therapeutic before the study. No asthmatic attack had been noted in the value. From the functional approach of asthmatic children during preceding 14 days and the clinical examination was free of sYmPa symptom-free period and from the values of their lung volumes, toms. NO patient had been receiving oral or inhaled corticosteroids total pulmonary flow resistance and dynamic lung compliance it or antihistaminics for at least 10 days. Sodium cromoglycate was would be possible to choose the most efficient bronchodilator. discontinued for at least 7 days and bronchodilators for at least 2 days. All patients had undergone pulmonary function tests before the assays and were thus familiar with the method applied. The The mainstay for bronchial asthma treatment is the use of drugs lung function investigations included measurement of the functo alleviate airway obstruction or to prevent its development. The tional residual capacity (FRC) using the closed helium dilution fundamental framework for diagnosis, grading of severity and method, the lung volumes and capacities (residual volume, expirpharmacologic management, was recently outlined by Ekwo and atory reserve volume, inspiratory capacity, and total lung capacity) Weinberger (8). Other reviews on the effects of different broncho-(10). Dynamic lung compliance (C dyn) and total pulmonary flow dilators and their mode of administration in asthmatic children resistance (RI) were measured by the usual methods (12). have been published recently (4, 24, 32-34). Administration of C dyn during normal frequency breathing was calculated from bronchodilator aerosols is a well-established treatment for airway simultaneous volume and intraesophageal pressure changes at obstruction in children with bronchial asthma (1-8, 14, 22, 27-30, zero flow points between the start and the end of the inspiration. 39). Drugs which may be administered include atropine-like The pressure changes were measured with a differential pressure agents (5, 6, 22) and, in order to minimize cardiac side-effects, transducer (Elema-Schonander EMT 34) connected to an esophaselective ,&-sympathomimetics. Recent studies have demonstrated gel catheter the tip of which was covered by a balloon. The considerable differences in the preferential efficiency of these balloon (length, 8 cm; circumference, 3 cm; wall thickness, 0.05 drugs on peripheral airways (42). It has been suggested (5, 6, 18, cm) was sealed over multiple perforations at the distal end of a polyethylene catheter (internal diameter 0.14 cm) 100 cm long. It exerted zero pressure at a gas volume in the balloon of 0.3 mlthe volume used for all measurements. The balloon was positioned through the nose in the midesophagus, in a position free from pressure artifacts (12). The volume displacement coefficient of the catheter-manometer system was about 0.002 ml/cm H20, and the 90% response time 0.02 sec. Gas flow rate at the mouth was measured with a heated Fleisch pneumotachometer (no. 2) connected to a differential transducer. The intraesophageal pressure and the flow changes as well as the integrated volume value< (Fenyves and Gut) were calibrated before each measurement and the response was linear over the range used. R1 was calculated between inspiratory and expiratory mid-tidal-iso-volume points from the intraesophageal pressure and the simultaneously recorded flow curves.
Controlled bronchial inhalation tests were performed by the technique of Geubelle (9, 13, 14, 28, 36, 37) with histamine aerosols in order to appreciate bronchial hyperreactivity. During the inhalation of histamine aerosol and the subsequent 6 min after administration of the bronchodilator, the intraesophageal pressure and the flow and the volume changes of the lung were continuously recorded. An increase of +loo% in the intraesophageal recordings assessed by eye was considered an indication of a ventilatory obstruction and the inhalation of histamine was immediately discontinued. For ethical reasons only one histamine provocation test was performed on each patient. Consequently one bronchodilator had been randomly chosen for each patient assay and given from a metered aerosol inhaler (2 x 0.20 mg; 1.3 18 pmole fenoterol, 2 x 0.10 mg; 0.835 pmole salbutamol, 2 x 0.25 mg; 1.648 pmole terbutaline, respectively). All inhalations were performed during two deep inspirations followed by a few seconds of breathholding. All the lung function tests were performed between 9 AM and 12 o'clock during the winter months.
The statistical evaluation has been performed by WilcoxonMann-Whitney rank analysis.
RESULTS
CLINICAL MATERIAL
Before the Inhalation of the Histamine Aerosol. The anthropometric data of the patients, the values of their lung volumes and capacities expressed in percentage of the predicted values (1 1, 12) as well as the threshold doses of histamine determined by the provocation test (9) are collected in Table 1 . The patients are rank ordered due to the base line value of the C dyn and divided into two groups.
All cases in group A fulfilled the following criteria: (1) the FRC is near the predicted value, (2) the C dyn is normal or decreased, and (3) the RI by the mean slightly increased. 
The ventilatory obstruction is demonstrated by the R1 increase and a ventilatory asynchronism is indicated by the C dyn decrease. Both, large and peripheral airways are obstructed.
All cases of group B present the three following criteria: The FRC and the C dyn are increased and RI is normal or decreased. A similar assumption concerning the possible trapped gas has to be considered. The ventilated lung units are hyperinflated and consequently the lung elastic recoil is increased. The pulling forces applied to the walls of the peripheral airways might explain the increase of the Cdyn: there is no obstruction of the peripheral airways and the specific compliance per litre of FRC is near the normal value in all cases.
Moreover, the distending forces are applied to the whole bronchial tree-the large as well as the more peripheral airways-and the resistance to the air flow is normal or, in most cases, below the predicted values.
The values of R1 show a wide variation within the two groups, not inversely related to the values of C dyn. Nevertheless, if the resistance is related to the concomitant lung volume and the specific conductance (sGL) is calculated it can be observed that the degree of impairment of the bronchial conductibility is about 20% in each group (sGI, % pred.: group A: 74.2 + 9.8 and group B: 87.2 + 13.7, not significantly different). Also the SGL in the randomly selected dr@ subgroGps is nearly equal (SGL pred.: salbutamol 83.0 + 13.4: terbutaline 88.3 + 17.1: fenoterol 89.5 +
19.7).
The scattering of the base line values of R1 and C dyn demonstrates clearly, that even the so called "symptom-free interval" lung function abnormalities can be present, which are not detected clinically.
The difference betwen the values in groups A and B is statistically significant for FRC ( P > 0.001), for residual volume ( P > 0.005), for total lung capacity ( P > 0.001), for C dyn/FRC ( P > 0.001), and for RI ( P > 0.05) (C dyn was taken as selection criterium). After Inhalation of the Histamine Aerosol. The threshold doses of response to histamine is not significantly different in both groups A and B.
Histamine induces a ventilatory obstruction of the large as well as of the small peripheral airways in both groups A and B. Indeed RI increases and C dyn decreases. The RI increase, in percentage of the predicted value, is actually larger in group B than in group A. But the RI values are similar in both groups after the respiratory challenge even if these values were in most cases lower than those predicted before the inhalation of histamine in group B.
Similarly, the drop of C dyn is larger in group B. But before the inhalation, C dyn was lower in most cases of group A: in those patients whose small airway calibre was normal or subnormal, histamine induced an obstruction of the large as well as of the small airways.
The bronchoconstricting effect of histamine is short. It is thus impossible to determine the lung volumes and capacities on the top of a provocation, for such measurements require at least 10 min.
Response of the Pz-Mimetics. Table 2 and Figures 1 and 2 illustrate the RI and the C dyn changes, respectively, after the inhalation of the p-mimetics.
Concerning the values of RL (indicating mostly the effect of the drugs on the large airways) the efficiency of the p-mimetics may be graded in the following way for both groups A and B: fenoterol, terbutaline and, the most efficient, salbutamol. In group A these differences are smaller than in group B.
Concerning the values of C dyn (indicating mostly the effect of the drugs on the small airways) the "obstructed" patients of group A have to be separated from the "overinflated" subjects of group B.
In patients of group A, terbutaline and fenoterol have little effect on C dyn. Salbutamol inhalations induce an increase of C dyn up to normal values. However, RI is still moderately increased in this salbutamol-subgroup. One may assume that at the end of the assay these patients are not overinflated and that the obstruction of the small airways are alleviated even if a moderate obstruction of the large bronchi is still observed. In patients of group B, terbutaline and fenoterol are immediately and significantly more efficient than salbutamol. Indeed the abnormally high values of Cdyn preexisting before the histamine inhalation, are observed after the administration of these two Pmimetics. One may assume that these patients are once again overinflated as before the assay: even if the large airways are still moderately obstructed (R1 being around 120% of the predicted values), the small bronchi are dilated (Cdyn being around 15% of the normal values).
At a first approach, salbutamol is less efficient than the two other p-mimetics: C dyn does not increase up to the values observed before the histamine inhalation. But in this subgroup RI is decreased up to the predicted value. One may assume that the obstruction of the large bronchi is fully alleviated, and in addition these patients are no longer overinflated. Table 3 gives a summary of the different statistical analyses. It becomes clear that the different response to salbutamol, namely in respect of C dyn changes, is the most pronounced.
DISCUSSION
Several recent studies concerning the mechanical factors involved in flow-limitation have demonstrated that conventional methods of detecting a ventilatory obstruction, such as measurement of pulmonary airway resistance to airflow, may fail to detect peripheral airway obstruction (18, 19, 23, 25, 31, 41). Moreover, forced breathing manoeuvres, such as forced vital capacities, forced expiratory volumes in 1 sec, and maximal flow volume curves require full cooperation from the subject, so the data obtained from children are less reproducible than those from trained adults (10, 15, 16, 40). In addition, attempts have been made to ascertain the decrease of Cdyn by increasing the respiratory frequency, assuming that this is a more sensitive method of detecting ventilatory obstruction of the small and peripheral airways (19, 26, 41) . This estimation of the frequency dependence of dynamic compliance also requires full cooperation from the patient and is therefore only of limited validity when performed on children. Moreover, the expiratory level (i.e., FRC) has to be known during this procedure (10, 26).
It is generally accepted that R1 changes reflect mainly alterations in the dimensions of large airways (17), so that a decrease of R1 after drug inhalation implies a dilation of these more central airways (e.g., the first 5 to 7 airway generations). In contrast, changes in C dyn are thought to be due to modifications in the
